SCHEMBL18459934

SCHEMBL18459934

NC(CO)C(=O)NC1CCCCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 9/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 1/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP3A4 P08684 1/20 0.48
EPHX2 P34913 1/20 0.48
HPGD P15428 2/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 1/20 0.43
BLM P54132 1/20 0.43
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MMP2 P08253 1/20 0.41
MMP8 P22894 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18459935 1.00 EPHX1 (0.48) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
Hydrochloric Acid SCHEMBL9718091 0.98 EPHX1 (0.47) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
Hydrochloric Acid SCHEMBL29244862 0.88 LMNA (0.45) ALDH1A1MAPTKDM4EEPHX2KMT2A
Hydrochloric Acid SCHEMBL5114605 0.88 LMNA (0.45) ALDH1A1MAPTKDM4EEPHX2KMT2A
SCHEMBL29410399 0.85 EPHX1 (0.48) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL28717994 0.85 EPHX1 (0.48) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL13457724 0.83 EPHX2 (0.50) EPHX2KMT2ALMNABLMMMP2
SCHEMBL12573061 0.83 EPHX1 (0.53) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL17690666 0.83 EPHX2 (0.50) EPHX2KMT2ALMNABLMMMP2
SCHEMBL17690627 0.83 EPHX2 (0.50) EPHX2KMT2ALMNABLMMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170028075-A1 INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES Ashvattha Therapeutics, Inc. 2017-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170028075-A1 INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES PAM, UACA, FLT1 EPHX1 4046/4885SMN1; SMN2 4617/4885NPC1 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.